Jason Harrill, DPM
Foot & Ankle Surgery · Mesa, AZNPI 1972563955
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (47.5%), royalties or licence payments and travel and lodging — rather than concentrated in one kind of arrangement. 56 manufacturers reported payments, led by Fusion Orthopedics USA, LLC at 32.1% of the total.
Across 254 payments — averaging $63.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Fusion Orthopedics USA, LLC$5K
- Treace Medical Concepts, Inc.$2K
- Fusion Orthopedics, LLC.$1K
- Vaporox, Inc.$1K
- Smith+Nephew$792
- Paragon 28, Inc.$699
- plus $5K from 50 others
What the payments were for
- Royalty or licence$6,58241%
- Travel & lodging$1,75211%
- Food & beverage$7,63647%
- Education$70%
- Gifts$1001%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LapiLock and Lapidus U Plate$4,304
- LapiLock$2,277
- PolyLock$1,121
- Lapiplasty System$1,098
- Product Portfolio$699
- LAPIPLASTY SYSTEM 1$512
- MOTOBAND$351
- Zynrelef$123
- Regeneten$113
- Twist knotless DEX$101
- DALVANCE$101
How this compares
$16,077 in reported general payments places this provider in the 80th percentile of 291 foot & ankle surgery providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 42 | $508 |
| Mupirocin | 23 | $209 |
| Oxycodone Hcl | 14 | $56 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Mesa
- Scott MalingMesa$382K
- Jordan SistoMesa$54K
- Clay ShumwayMesa$32K
- Justin SinghMesa$30K
- Chase MoffatMesa$24K
- Christopher SuykerbuykMesa$13K
- Nathan JeppesenMesa$10K
- Ryan ScottPhoenix$1.1M
- Jeffrey McAlisterScottsdale$578K
- Jeffrey HolmesPhoenix$509K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.